Cargando…
Engineering chimeric human and mouse major histocompatibility complex (MHC) class I tetramers for the production of T-cell receptor (TCR) mimic antibodies
Therapeutic monoclonal antibodies targeting cell surface or secreted antigens are among the most effective classes of novel immunotherapies. However, the majority of human proteins and established cancer biomarkers are intracellular. Peptides derived from these intracellular proteins are presented o...
Autores principales: | Li, Demin, Bentley, Carol, Yates, Jenna, Salimi, Maryam, Greig, Jenny, Wiblin, Sarah, Hassanali, Tasneem, Banham, Alison H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407768/ https://www.ncbi.nlm.nih.gov/pubmed/28448627 http://dx.doi.org/10.1371/journal.pone.0176642 |
Ejemplares similares
-
Comprehensive mutagenesis identifies the peptide repertoire of a p53 T-cell receptor mimic antibody that displays no toxicity in mice transgenic for human HLA-A*0201
por: Trenevska, Iva, et al.
Publicado: (2021) -
High-Throughput Identification of Potential Minor Histocompatibility Antigens by MHC Tetramer-Based Screening: Feasibility and Limitations
por: Hombrink, Pleun, et al.
Publicado: (2011) -
TCR-Like CAR-T Cells Targeting MHC-Bound Minor Histocompatibility Antigens
por: Akatsuka, Yoshiki
Publicado: (2020) -
One-Pot, Mix-and-Read Peptide-MHC Tetramers
por: Leisner, Christian, et al.
Publicado: (2008) -
Visualizing Antigen Specific CD4+ T Cells using MHC Class II Tetramers
por: James, Eddie A., et al.
Publicado: (2009)